Analysis in progress
Initialising…
0%
complete
This report is still being assembled — sections appear as each stage finishes. It isn't final yet.
ATM
Final classification
Pathogenic
ATM c.4818dup · p.Pro1607SerfsTer6
ATM

NM_000051.3:c.4818dupT (p.Pro1607SerfsTer6) is a frameshift duplication in exon 32 of ATM predicted to cause nonsense-mediated decay and complete loss of ATM protein function (PVS1_VeryStrong).

Gene
ATM
Transcript
NM_000051.3
HGVS · transcript:coding
NM_000051.3:c.4818dup
Consequence
N/A
GRCh38
chr11:108294966 C>CT
GRCh37
chr11:108165693 C>CT
Basis Richards et.al., 2015 - Combining rules v1.5.0 criteria-combination framework: matched Rule4 (1 Pathogenic.Very Strong + Pathogenic.Supporting >=2) with applied criteria: PVS1 very strong, PM2 supporting, PM5 supporting; maps to Pathogenic.
Richards et.al., 2015 - Combining rules v1.5.0 criteria-combination framework: matched Rule4 (1 Pathogenic.Very Strong + Pathogenic.Supporting >=2) with applied criteria: PVS1 very strong, PM2 supporting, PM5 supporting; maps to Pathogenic.
Classification rationale
PVS1PM2PM5 Pathogenic
ATM c.4818dup

NM_000051.3:c.4818dupT (p.Pro1607SerfsTer6) is a frameshift duplication in exon 32 of ATM predicted to cause nonsense-mediated decay and complete loss of ATM protein function (PVS1_VeryStrong).1 The variant is absent from gnomAD v4.1 population database (0/1,614,094 alleles), meeting the ATM VCEP PM2_Supporting threshold of ≤0.001% allele frequency.2 The premature termination codon at p.Pro1607SerfsTer6 lies upstream of p.Arg3047, satisfying the ATM VCEP PM5_Supporting rule for frameshifting variants with PTCs upstream of this C-terminal boundary.3 No variant-specific functional studies, case-control data, co-segregation data, or co-occurrence data were identified for this variant in the literature screened (PMID:27413114, PMID:30348496, PMID:30553448). The variant is not present in ClinVar and has not been reported in COSMIC or in statistically significant mutational hotspots.4

PVS1 + PM2 + PM5 Pathogenic
Gene diagram · NM_000051.3 · variants mapped to exon structure
ATM NM_000051.3
Fetching transcript structure from UCSC…
Applied criteria · 3 applied · 7 assessed
Applied · 3
Strength Supporting Moderate Strong Very strong
PVS1 very strong Pathogenic
Frameshift variant NM_000051.3:c.4818dup (p.Pro1607SerfsTer6) creates a premature termination codon at residue 1612 in ATM, a gene where loss of function is an established mechanism for ataxia-telangiectasia and hereditary breast/ovarian/pancreatic cancer. The PTC is NMD-competent and lies well upstream of the C-terminal boundary (p.Arg3047) specified by the ATM VCEP v1.5.0 PVS1 decision tree. PVS1_VeryStrong applied per ClinGen HBOP VCEP specifications.
NM_000051.3:c.4818dup is a frameshift duplication in exon 32 of 63 coding exonsPredicted protein consequence: NP_000042.3:p.(Pro1607SerfsTer6)PTC at codon 1612 of 3056
PM2 supporting Pathogenic
NM_000051.3:c.4818dupT is absent from gnomAD v4.1 (0 alleles, AF=0), satisfying the ATM VCEP PM2_Supporting threshold of ≤0.001% population frequency.
gnomAD v4.1: 0 allelesallele frequency = 0gnomAD v2.1: absent
PM5 supporting Pathogenic
This frameshift variant creates a premature termination codon at p.Pro1607SerfsTer6 (PTC at codon 1612), which lies upstream of p.Arg3047, satisfying the ATM VCEP v1.5.0 PM5_Supporting rule for frameshifting/truncating variants with PTCs upstream of p.Arg3047.
Predicted protein: NP_000042.3:p.(Pro1607SerfsTer6)PTC at codon 1612p.Arg3047 is the VCEP-specified C-terminal cutoff for PM5 application
Assessed · not applied
Pathogenic
PS3 No variant-specific functional studies were identified for NM_000051.3:c.4818dupT.
PS4 No case-control study data are available for NM_000051.3:c.4818dupT.
PP1 No co-segregation data are available for NM_000051.3:c.4818dupT.
Benign
BA1 NM_000051.3:c.4818dupT is absent from gnomAD v4.1 (0 alleles).
BS1 NM_000051.3:c.4818dupT is absent from gnomAD v4.1 (0 alleles).
BS3 No variant-specific functional rescue data are available for NM_000051.3:c.4818dupT.
BP2 No co-occurrence data in trans with a known pathogenic ATM variant are available for NM_000051.3:c.4818dupT.
N/A · 17 PS1 · PS2 · PM1 · PM4 · PM6 · PP2 · PP3 · PP4 · PP5 · BS2 · BS4 · BP1 · BP3 · BP4 · BP5 · BP6 · BP7
Research & evidence
Population frequency · supports pathogenic
gnomAD v4.1 screenshot
gnomAD v4.1
gnomAD v2.1 screenshot
gnomAD v2.1
v4.1
Absent from gnomAD v4.1.
v2.1
Absent from gnomAD v2.1.
🇨🇦 CA
Absent from gnomAD-Canada v1.0.
Allele frequency by ancestry
three datasets · side by side
gnomAD v4.1
Absent · 0 / ?
0 hom
Not observed in any ancestry group.
gnomAD v2.1
Absent · 0 / ?
0 hom
Not observed in any ancestry group.
gnomAD Canada 🇨🇦
Absent · 0 / ?
0 hom
Not observed in any ancestry group.
ClinVar screenshot
ClinVar
This variant is absent from ClinVar.
SpliceAI screenshot
In silico
SpliceAI predicts possible splice impact for this variant (max delta score = 0.24).
Functional / OncoKB screenshot
Functional Likely Oncogenic
OncoKB identified variant-specific curated literature and context relevant to functional review; biological-effect context: Likely Loss-of-function; curated oncogenicity label: Likely Oncogenic.
OncoKB ↗
COSMIC screenshot
COSMIC
Cancer hotspots screenshot
Cancer hotspots
Somatic evidence Not in COSMIC / hotspots
COSMIC
This variant does not lie in a statistically significant hotspot. This variant has not previously been reported in somatic cancers (COSMIC).
Hotspots
This variant does not lie in a statistically significant hotspot.
Sources & reference links
9Sources
CSpec VCEP
ClinVar
gnomAD v2.1
gnomAD v4.1
gnomAD-Canada
SpliceAI
OncoKB
COSMIC
Cancer hotspots
Triaged references · 3 PMIDs not cited in assessment
27413114 ↗ ATM Mutations in Cancer: Therapeutic Implications. ONCOKB
30348496 ↗ Inactive Atm abrogates DSB repair in mouse cerebellum more than does Atm loss, without causing a neurological phenotype. ONCOKB
30553448 ↗ Loss of ATM positively regulates Rac1 activity and cellular migration through oxidative stress. ONCOKB